Log in | Register

High-Performance Product Verification System

For the latest pharmaceutical news and updates - Sign up now!
Loading...
High-Performance Product Verification System

VeriSym®SL is a new mid-volume, high-performance optical inspection system for verifying solid dose pharmaceuticals and nutraceuticals.  The system inspects up to 500,000 softgel capsules or tablets per hour, verifying product color, size and shape while also removing defects and foreign capsules and tablets from the product stream to assure product quality. The cost-effective single-lane system offers the same capabilities as the original two-lane, full-capacity VeriSym, but with half the maximum capacity, making it ideal for smaller manufacturers and contract packers of OTC and regulated softgels and tablets.  The modular system can be upgraded in the field at a later date to achieve full capacity — 1,000,000 softgels or tablets per hour — to accommodate growing demand. The system removes defects such as broken tablets, stained tablets, tablets with missing coating (if the coating is a different color than the underlying tablet), softgels with air bubbles,stained capsules and misshapen product. The company designed VeriSym SL/N for nutraceuticals and VeriSym SL/P for OTC and regulated pharmaceuticals.  The /P model is FDA 21 CFR part 11 compliant with secure and encrypted logs, secure passcode management, parameter histograms and guided changeover.  The /Pmodel also features a parallel processor that enables operators to monitor images of every object of interest, such as unconfirmed objects.  Because the SL uses the same software and hardware as the full-capacity VeriSym introduced last year, the new system is easy to validate. The system uses proprietary color cameras to view product — two primary inspection cameras are located above and below the product stream.  The company’s image processing technology quickly analyzes the product images, comparing each object to previously defined accept/reject standards.  When a defective product or unconfirmed object is identified, the system activates the close-coupled high-speed ejector system to remove it from the acceptable product stream.  The system can be programmed to send an alarm or stop the product flow when an unconfirmed object is detected, which prevents unconfirmed objects from being accepted. The system can be cleared, cleaned and set up to handle the next product in 20 minutes.  Product settings can be stored in memory for quick and easy recall via the icon-based graphical user interface(GUI), which resides on a pendant-style touch screen that enables operator access from either side of the system.  In addition to residing locally, the GUI can be accessed remotely via network or Internet. Designed to meet FDA requirements and comply with GAMP guidelines,VeriSym SL benefits from the company’s 10-year history of supplying FDA-validated inspection systems to the pharmaceutical industry. 



Symetix,Walla Walla, WA  99362. www.symetix.com or call 800-941-3701

Register or log in to send e-mail for more info

E-mail to a colleague

See company's other products

Join the Discussion
Rate Article:  Average 0 out of 5
register or log in to comment on this article!

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

Blogs

The Tale of Two Deviations

The Tale of Two Deviations

Apr 23 | The QA Pharm

It stands to reason that pharmaceutical companies in compliance trouble also have problems with their Deviation Management and Corrective and Preventive Action (CAPA) System(s).

Can the Combination of Creative Destruction and “Steve Jobs’ Traits” Lead to a “Pharma QbD Spring”?

Can the Combination of Creative Destruction and “Steve Jobs’ Traits” Lead to a “Pharma QbD Spring”?

Apr 16 | Girish Malhotra, PE, President, EPCOT International

The answer is an unequivocal yes but we need some outsiders who can conspire with the insiders who will be the flag bearers within the companies. Outsiders can be the counsels/co-conspirators to the insiders for the coup d'etat.

Multimedia

Lung Cancer Drug Treats Rare Lymphoma Tumors

Lung Cancer Drug Treats Rare Lymphoma Tumors

May 17 | Video

A new study found Xalkori effective in treating anaplastic lymphoma among children, an encouraging development for gene-targeted therapy.

Merck - 2012 Facility of the Year Award - Facility Integration

Merck - 2012 Facility of the Year Award - Facility Integration

May 14 | Video

Brian Morrissey, Senior Project Engineer, Merck Manufacturing Division, talks to Pharmaceutical Processing's Editor In Chief Mike Auerbach during INTERPHEX 2012 about the company's Vaccine Bulk Manufacturing Facility Program of Projects. The facility has won the Facility Integration award in the 2012 Facility of the Year Award competition sponsored by ISPE, INTERPHEX and Pharmaceutical Processing magazine.

Medicine from a Vending Machine?

Medicine from a Vending Machine?

May 3 | Video

A Chinese company is pushing for acceptance of traditional Chinese medicine with a machine that can dispense herbs.

Taking Precautions to Prevent Contagion

Taking Precautions to Prevent Contagion

Apr 29 | Video

With the recent outbreak of viruses such as SARS, bird flu and swine flu, officials and travelers are being extra careful about preventing the illnesses from being transmitted.

Top Stories and Headlines
EVERY DAY!

FREE Email Newsletter